A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer. [electronic resource]
Producer: 20170526Description: 949-958 p. digitalISSN:- 1432-0843
- Administration, Intravenous
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Combinations
- Female
- Gastrointestinal Neoplasms -- drug therapy
- Humans
- Irinotecan
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Oxonic Acid -- administration & dosage
- Tegafur -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.